Advertisement
Advertise Here
-
October 3, 2011
[an error occurred while processing this directive]
Forensic Chemistry: A new method could increase the number of explosives detected by airport screeners.
Trade: U.S. companies complain of market dumping by China.
Layoffs follow similar moves by Amgen, AstraZeneca.
Environment: Ban to halt export of hazardous waste to developing world.
Penrose (Parney) Albright will direct DOE national lab.
Toxic Exposure: Mercury isotopes in human hair illuminate dietary and industrial sources.
Cancer Biochemistry: Mass spectrometry follows the metabolism of very long fatty acids in cancer cells.
Tracking a drug's destination in human tissue is now possible thanks to mass spectrometry imaging (Anal. Chem., DOI: 10.1021/ac2014349).
Scientists want to track drugs to find out whether they reach their intended targets in specific tissues. Doctors also think such mapping could help them tailor medicine to their patients. Traditional imaging techniques require adding a chemical label to the drug. However, these labels can change the drug's behavior.
Researchers led by György Marko-Varga from Lund University, in Sweden, wanted to develop a label-free method. So they harnessed matrix-assisted laser desorption ionization (MALDI) mass spectrometry imaging to map the fate of an inhaled drug in tissue biopsies from five patients' lungs.
The patients, who were long-time smokers, reported improved breathing after inhaling ipratropium, a common drug that opens airways in the lungs by binding to receptors in smooth muscle tissue. Researchers analyzed 3,000 0.01-mm2 spots on each tissue sample to create an image showing the drug's spatial distribution in the tissue. Their maps found that the drug had reached smooth muscle tissue in four of the patients.
The team had previously tested its technique on the tissues of rats given drug doses 100 times greater than those used in this study (Plos One, DOI: 10.1371/journal.pone.0011411). In the two years since then, the team improved the technique's sensitivity so that they can image therapeutic doses in humans, says Thomas Fehniger, from Tallin University of Technology, in Estonia, who is first author of the study. The technique, he says, could help doctors understand which tissues a drug targets so that they can choose the right drug for each patient's condition.
ACS is the leading employment source for recruiting scientific professionals. ACS Careers and C&EN Classifieds provide employers direct access to scientific talent both in print and online. Jobseekers | Employers
Join more than 161,000 professionals in the chemical sciences world-wide, as a member of the American Chemical Society.
» Join Now!